Who owns TG Therapeutics (TGTX)? Superinvestor holders

2 superinvestors of the 157 tracked here hold TG Therapeutics (TGTX) in their latest 13F filing, with $33M between them. Ray Dalio (founder) gives it the most weight: 0.14% of the reported portfolio. In their latest reported quarter, Larry Robbins opened a position; Ray Dalio (founder) added.

Among the 156 filings in for Q3 2026, 2 investors held it; in Q4 2024, with the same number of filings on file, 0 did.

Hold it now
2
of 157 tracked
Combined value
$33M
Bought / sold
2 / 0
last quarter

Key facts

Superinvestors holding it
2 of 157
Biggest holder
Ray Dalio (founder), $32.7M
Largest weight
Ray Dalio (founder), 0.14%of their portfolio
Combined value
$33M
Bought last quarter
2
Sold last quarter
0

From each investor's latest 13F filing: 156 investors report Q3 2026, 1 investor reports Q2 2026. Latest filing in this set: Nov 17, 2026.

Superinvestors holding TGTX, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Ray Dalio (founder)Bridgewater Associates0.14%$32.7M586.63K▲ Added 36%+156.74KQ3 2026
2Larry RobbinsGlenview Capital Management0.01%$267.7K4.8KNew+4.8KQ3 2026

Quarter by quarter

Superinvestor ownership of TGTX by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20261562591.43K$33M20
Q2 20261570——00
Q1 20261570——00
Q4 20251570——00
Q3 20251570——01
Q2 20251570——00
Q1 20251560——00
Q4 20241560——00

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of TGTX held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Ray Dalio (founder)586.63K———————
Larry Robbins4.8K———————

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own TGTX?

In their latest 13F filings: Ray Dalio (founder) (0.14% of the portfolio, $32.7M), Larry Robbins (0.01% of the portfolio, $267.7K).

Who bought TGTX last quarter?

Ray Dalio (founder) (added 36%), Larry Robbins (new position). “Last quarter” is each investor's latest reported quarter.

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 17, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns TG Therapeutics (TGTX)? Superinvestor holders”, data as of 17 November 2026. https://funkfolio.com/stock/TGTX/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to TGTX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.